% | $
Quotes you view appear here for quick access.

Medivation, Inc. Message Board

  • riskybiz1111 riskybiz1111 May 17, 2013 10:03 AM Flag

    What Do Medivation And AtheroNova Have In Common?

    Medivation Inc. (NASDAQ: MDVN) is a classic Wall Street success story. Founded by a group of experienced professionals, the company acquired early stage pharmaceuticals and medical devices that had promising clinical, intellectual property and commercial prospects and grew from just $5.00 per share in 2010 to more than $40.00 per share three years later. The majority of this growth happened in late 2011/early 2012, when the stock appreciated nearly 500% after successful clinical trials unlocked significant value in its product pipeline. [1]
    Behind the scenes of this success, was biotech investment fund manager Fred Knoll, via his firm Knoll Capital Management, as a key investor. The fund began building a stake in the company in early 2006, where it acquired about $7.2 million worth of stock, according to regulatory filings. By the same time in 2007, the fund had more than doubled its share ownership and the $66 million position became the largest in its portfolio. And, according to the fund’s most recent regulatory filings, the stake is now worth more than $130 million today.

41.17+0.55(+1.35%)Nov 25 4:00 PMEST